Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.

Stefka AT, Johnson D, Rosebeck S, Park JH, Nakamura Y, Jakubowiak AJ. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models. Cancer Med. 2020 01; 9(1):324-334.

View in: PubMed

collapse authors with profiles